Physical performance imposes an increased demand for nutrients and oxygen in the body. In order to achieve the best possible results in sports, individuals, commonly athletes, resort to performance-enhancing drugs (PEDs) as shortcuts to succeed and increase their ability to perform. This is known to be as doping. Doping consists of the use of various substances to help improve performance by targeting strength, alertness, speed and levels of oxygen in the blood, despite the adverse health effects with which it is associated.
The video was made by Health Science 4DM3 students Rebecca Vinet, Dissneya Theiventhirarajah, Forum Trivedi and Stanis Xavier.
Copyright McMaster University 2018.
Cazzola, M. (2000). A global strategy for prevention and detection of blood doping with erythropoietin and related drugs.
Jeschke, J., Nekola, J., & Chlumský, J. (1999). Doping in sports. Casopis lekaru ceskych, 138(10), 291-297.
Nieschlag, E., & Vorona, E. (2015). Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions. Reviews in Endocrine and Metabolic Disorders, 16(3), 199-211.
Laure, P. (1997). Epidemiologic approach of doping in sport. A review.
Siri, F., & Roques, B. P. (2003, November). Doping: health risks and relation to addictive behaviors. In Annales de medecine interne (Vol. 154, pp. S43-57).
Sjöqvist, F., Garle, M., & Rane, A. (2008). Use of doping agents, particularly anabolic steroids, in sports and society. The Lancet, 371(9627), 1872-1882.
Robinson, N., Giraud, S., Saudan, C., Baume, N., Avois, L., Mangin, P., & Saugy, M. (2006). Erythropoietin and blood doping. British journal of sports medicine, 40(suppl 1), i30-i34.
Taware, G. B., & Bansode, D. G. (2015). Doping in sports. NJBMS, 6.
Thieme, D., & Hemmersbach, P. (Eds.). (2009). Doping in sports (Vol. 195). Springer Science & Business Media.